Risers and fallers: Fresnillo glistens, while Tate's in a state
Some of the main news-driven share price changes at 3.30pm.
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 46 of 55
Drugs stocks boosted by Clinton defeat
Markets have reacted badly to Trump's electoral victory, but some sectors have benefited
Archive
Brokers: UK pharma giants in good shape if Clinton wins says Citigroup
“From a legislative angle, we continue to prefer names with either limited part D exposure [US Medicare] or heavier contribution of non-pharma assets."
Week Ahead: US election takes centre stage
Aside from the election, several UK retailers have results due next week
Investments and investor services
FTSE 100 drops on miners and drugs
FTSE 100 shares fell on Monday led by pharma Hikma
Proactive news summary – Mirada, Tissue Regenix, Synairgen and Vast Resources
A selection of the day's significant news stories from the junior AIM market
Archive
Salesforce.com gets battered but it has a fan in Exane
Exane is less concerned about any potential bid by Salesforce.com for Twitter than it is about the exciting deal it has just done
Investments and investor services
FTSE 100 nears May 2015 highs after data and sterling fall
FTSE 100 shares had a good start to the fourth quarter, helped by good manufacturing data and hopes that the pound's sharp fall on Monday will help exporters
RBS has a shocker post-Brexit
It was better news for the miners which have rallied since June’s EU referendum
AstraZeneca up after diabetes combo passes phase III
The trial met the met the primary endpoint of a better performance that the single medicines alone said the pharma
Ocado gets another pasting over margin warning
Exane BNP Paribas downgrades online grocer after it warned of margin pressure from rivals
Broker talks up AstraZeneca's lung cancer drug prospects
Jefferies upgraded the health giant to a 'buy' recommendation
Investments and investor services
London shares close lower as Fed Lockhart comments boost US rate hike risk
London shares ended lower on Monday after comments from Fed official Dennis Lockhart added to the chorus of central bankers calling US rates higher next week
Redx Pharma welcomes former AstraZeneca executive
Karl Hård, formerly at pharma titan AstraZeneca PLC has joined executive management as head of investor relations and corporate communications
AstraZeneca’s new asthma drug: “Late to the game, but potentially best in class”
This week AstraZeneca announced a next-generation asthma drug that would see it locking horns with fellow pharma giants over treatments already out there.
AstraZeneca asthma treatment does well in final trial
The new drug reduced wheeze, cough, chest tightness and shortness of breath
UK shares surge, rub out previous day’s losses, as miners stage a comeback
London shares closed sharply higher on Friday and more than erased the previous session’s losses as two unlikely bedfellows – tobacco and pharma stocks – led the gains alongside a rebound by miners which had a difficult week
FTSE 100 sitting pretty ahead of US jobs report
An unlikely combination of tobacco and drugs stocks are driving the top-share index's advance
UK stocks gains after Fed’s Yellen comments, miners dominate after zinc price gains
London stocks closed higher on Friday, feeding off the initial optimism of Wall Street investors over comments from the US central bank’s chief Janet Yellen, while 15-month highs for zinc prices made miners dominate the skyline